dc.contributor | Universidade Estadual de Londrina (UEL) | |
dc.contributor | Londrina Hosp Canc | |
dc.contributor | Hlth Sci Ctr | |
dc.contributor | Universidade Estadual Paulista (Unesp) | |
dc.date.accessioned | 2014-05-20T13:34:26Z | |
dc.date.accessioned | 2022-10-05T13:43:23Z | |
dc.date.available | 2014-05-20T13:34:26Z | |
dc.date.available | 2022-10-05T13:43:23Z | |
dc.date.created | 2014-05-20T13:34:26Z | |
dc.date.issued | 2010-11-01 | |
dc.identifier | Cancer Investigation. Philadelphia: Taylor & Francis Inc, v. 28, n. 9, p. 917-924, 2010. | |
dc.identifier | 0735-7907 | |
dc.identifier | http://hdl.handle.net/11449/11801 | |
dc.identifier | 10.3109/07357907.2010.483509 | |
dc.identifier | WOS:000282753800005 | |
dc.identifier | 2259986546265579 | |
dc.identifier.uri | http://repositorioslatinoamericanos.uchile.cl/handle/2250/3887739 | |
dc.description.abstract | The study of genes involved in androgen pathway can contribute to a better knowledge of prostate cancer. Our aim was to examine if polymorphisms in prostate-specific antigen (PSA) and androgen receptor (AR) genes were involved in prostate cancer risk and aggressiveness. Genotypes were determined by PCR-RFLP (PSA) or using a 377 ABI DNA Sequencer (AR). PSA(G/G) genotype (OR = 1.78, 95% CI = 1.06-2.99) and AR short CAG repeats (OR = 1.89, 95% CI = 1.21-2.96) increased risk for prostate cancer and were related with tumor aggressiveness. About 38.3% of tumors showed microsatellite instability. In conclusion, polymorphisms in these genes may be indicated as potential biomarkers for prostate cancer. | |
dc.language | eng | |
dc.publisher | Taylor & Francis Inc | |
dc.relation | Cancer Investigation | |
dc.relation | 2.053 | |
dc.relation | 0,858 | |
dc.rights | Acesso restrito | |
dc.source | Web of Science | |
dc.subject | AR gene | |
dc.subject | Gleason score | |
dc.subject | Histopathological parameters | |
dc.subject | Polymorphisms | |
dc.subject | Prostate Cancer | |
dc.subject | PSA gene | |
dc.title | Polymorphisms in the AR and PSA Genes as Markers of Susceptibility and Aggressiveness in Prostate Cancer | |
dc.type | Artigo | |